Trial NCT01036399

View at ClinicalTrials.gov 
Org. Study IDs: RV-PTCL-PI-277
Secondary IDs: 2007-003911-29

Last trial update was posted on 2012-08-27

MeSH Interventions

Lenalidomide

MeSH Conditions

Lymphoma Lymphoma, T-Cell Lymphoma, T-Cell, Peripheral

Other Conditions

Peripheral T-cell Lymphoma

Stopping Reasons

The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID